Suppr超能文献

植物糖生物技术迈向合成生物学之路。

Plant glyco-biotechnology on the way to synthetic biology.

机构信息

Department of Applied Genetics and Cell Biology, University of Natural Resources and Life Sciences Vienna, Austria.

出版信息

Front Plant Sci. 2014 Oct 8;5:523. doi: 10.3389/fpls.2014.00523. eCollection 2014.

Abstract

Plants are increasingly being used for the production of recombinant proteins. One reason is that plants are highly amenable to glycan engineering processes and allow the production of therapeutic proteins with increased efficacies due to optimized glycosylation profiles. Removal and insertion of glycosylation reactions by knock-out/knock-down approaches and introduction of glycosylation enzymes have paved the way for the humanization of the plant glycosylation pathway. The insertion of heterologous enzymes at exactly the right stage of the existing glycosylation pathway has turned out to be of utmost importance. To enable such precise targeting chimeric enzymes have been constructed. In this short review we will exemplify the importance of correct targeting of glycosyltransferases, we will give an overview of the targeting mechanism of glycosyltransferases, describe chimeric enzymes used in plant N-glycosylation engineering and illustrate how plant glycoengineering builds on the tools offered by synthetic biology to construct such chimeric enzymes.

摘要

植物越来越多地被用于生产重组蛋白。原因之一是植物非常适合糖基工程过程,并且由于优化的糖基化谱,可以生产出疗效更高的治疗性蛋白。通过敲除/敲低方法去除和插入糖基化反应,并引入糖基化酶,为植物糖基化途径的人源化铺平了道路。在现有糖基化途径的精确阶段插入异源酶已被证明是至关重要的。为了实现这种精确的靶向,已经构建了嵌合酶。在这篇简短的综述中,我们将举例说明正确靶向糖基转移酶的重要性,概述糖基转移酶的靶向机制,描述用于植物 N-糖基化工程的嵌合酶,并说明植物糖基工程如何利用合成生物学提供的工具来构建这种嵌合酶。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3256/4189330/ec3c8734c40e/fpls-05-00523-g001.jpg

相似文献

1
Plant glyco-biotechnology on the way to synthetic biology.
Front Plant Sci. 2014 Oct 8;5:523. doi: 10.3389/fpls.2014.00523. eCollection 2014.
2
Controlled glycosylation of plant-produced recombinant proteins.
Curr Opin Biotechnol. 2014 Dec;30:95-100. doi: 10.1016/j.copbio.2014.06.008. Epub 2014 Jul 5.
3
Synthetic Glycobiology: Parts, Systems, and Applications.
ACS Synth Biol. 2020 Jul 17;9(7):1534-1562. doi: 10.1021/acssynbio.0c00210. Epub 2020 Jun 30.
4
Plant glycoengineering for designing next-generation vaccines and therapeutic proteins.
Biotechnol Adv. 2023 Oct;67:108197. doi: 10.1016/j.biotechadv.2023.108197. Epub 2023 Jun 12.
5
Unexpected Arabinosylation after Humanization of Plant Protein -Glycosylation.
Front Bioeng Biotechnol. 2022 Feb 18;10:838365. doi: 10.3389/fbioe.2022.838365. eCollection 2022.
6
Advances in bacterial glycoprotein engineering: A critical review of current technologies, emerging challenges, and future directions.
Biotechnol Adv. 2025 Mar-Apr;79:108514. doi: 10.1016/j.biotechadv.2024.108514. Epub 2025 Jan 2.
7
Plant glyco-biotechnology.
Semin Cell Dev Biol. 2018 Aug;80:133-141. doi: 10.1016/j.semcdb.2017.07.005. Epub 2017 Jul 5.
8
Suborganellar resolution imaging for the localisation of human glycosylation enzymes in tobacco Golgi bodies.
J Microsc. 2025 Mar;297(3):258-273. doi: 10.1111/jmi.13311. Epub 2024 Apr 30.
9
Glyco-engineering of biotherapeutic proteins in plants.
Mol Cells. 2008 Jun 30;25(4):494-503. Epub 2008 Apr 23.

引用本文的文献

1
Recent advances in expression and purification strategies for plant made vaccines.
Front Plant Sci. 2023 Nov 23;14:1273958. doi: 10.3389/fpls.2023.1273958. eCollection 2023.
2
Giant Viruses as a Source of Novel Enzymes for Biotechnological Application.
Pathogens. 2022 Dec 1;11(12):1453. doi: 10.3390/pathogens11121453.
4
Producing Biologics with Defined N-Glycosylation in Plants.
Methods Mol Biol. 2023;2597:235-250. doi: 10.1007/978-1-0716-2835-5_17.
5
Potential for a Plant-Made SARS-CoV-2 Neutralizing Monoclonal Antibody as a Synergetic Cocktail Component.
Vaccines (Basel). 2022 May 12;10(5):772. doi: 10.3390/vaccines10050772.
6
Development of plant-made monoclonal antibodies against viral infections.
Curr Opin Virol. 2022 Feb;52:148-160. doi: 10.1016/j.coviro.2021.12.005. Epub 2021 Dec 18.
7
8
Transient Production of Human β-Glucocerebrosidase With Mannosidic-Type -Glycan Structure in Glycoengineered Plants.
Front Plant Sci. 2021 Jun 7;12:683762. doi: 10.3389/fpls.2021.683762. eCollection 2021.
9
Development and Expression of Subunit Vaccines Against Viruses in Plants.
Methods Mol Biol. 2021;2225:25-38. doi: 10.1007/978-1-0716-1012-1_2.
10
Functional characterization of three flavonoid glycosyltransferases from .
R Soc Open Sci. 2019 Jun 12;6(6):190150. doi: 10.1098/rsos.190150. eCollection 2019 Jun.

本文引用的文献

1
Studying "secret serums"--toward safe, effective Ebola treatments.
N Engl J Med. 2014 Sep 18;371(12):1086-9. doi: 10.1056/NEJMp1409817. Epub 2014 Aug 20.
2
GlycoDelete engineering of mammalian cells simplifies N-glycosylation of recombinant proteins.
Nat Biotechnol. 2014 May;32(5):485-9. doi: 10.1038/nbt.2885. Epub 2014 Apr 20.
3
Glycan variants of a respiratory syncytial virus antibody with enhanced effector function and in vivo efficacy.
Proc Natl Acad Sci U S A. 2014 Apr 22;111(16):5992-7. doi: 10.1073/pnas.1402458111. Epub 2014 Apr 7.
4
Plant genome engineering in full bloom.
Trends Plant Sci. 2014 May;19(5):284-7. doi: 10.1016/j.tplants.2014.02.014. Epub 2014 Mar 24.
5
Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology.
Mol Genet Metab. 2014 May;112(1):1-8. doi: 10.1016/j.ymgme.2014.02.011. Epub 2014 Mar 2.
7
Plant molecular pharming for the treatment of chronic and infectious diseases.
Annu Rev Plant Biol. 2014;65:743-68. doi: 10.1146/annurev-arplant-050213-035850. Epub 2014 Feb 24.
8
What's fueling the biotech engine-2012 to 2013.
Nat Biotechnol. 2014 Jan;32(1):32-9. doi: 10.1038/nbt.2794.
9
Genentech's glyco-engineered antibody to succeed Rituxan.
Nat Biotechnol. 2014 Jan;32(1):6-7. doi: 10.1038/nbt0114-6b.
10
Plant viral vectors for delivery by Agrobacterium.
Curr Top Microbiol Immunol. 2014;375:155-92. doi: 10.1007/82_2013_352.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验